465 related articles for article (PubMed ID: 29500339)
21. NLRP3 inflammasome activation regulated by NF-κB and DAPK contributed to paraquat-induced acute kidney injury.
Liu Z; Wang X; Wang Y; Zhao M
Immunol Res; 2017 Jun; 65(3):687-698. PubMed ID: 28215032
[TBL] [Abstract][Full Text] [Related]
22. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
23. Autophagy Induction Ameliorates Inflammatory Responses in Intestinal Ischemia-Reperfusion Through Inhibiting NLRP3 Inflammasome Activation.
Wang Z; Li Z; Feng D; Zu G; Li Y; Zhao Y; Wang G; Ning S; Zhu J; Zhang F; Yao J; Tian X
Shock; 2019 Sep; 52(3):387-395. PubMed ID: 30216227
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction.
He Q; Li Z; Wang Y; Hou Y; Li L; Zhao J
Int Immunopharmacol; 2017 Sep; 50():208-215. PubMed ID: 28683365
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
[TBL] [Abstract][Full Text] [Related]
26. NLRP3 inflammasome in rosmarinic acid-afforded attenuation of acute kidney injury in mice.
Akhter J; Khan J; Baghel M; Beg MMA; Goswami P; Afjal MA; Ahmad S; Habib H; Najmi AK; Raisuddin S
Sci Rep; 2022 Jan; 12(1):1313. PubMed ID: 35079027
[TBL] [Abstract][Full Text] [Related]
27. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages.
Chen Y; Huang Y; Xiong B; Luo H; Song X
Gene; 2020 Oct; 758():144973. PubMed ID: 32707303
[TBL] [Abstract][Full Text] [Related]
28. Parkin-Dependent Mitophagy is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia-Reperfusion Injury in Rats.
He Q; Li Z; Meng C; Wu J; Zhao Y; Zhao J
Cells; 2019 Aug; 8(8):. PubMed ID: 31416289
[TBL] [Abstract][Full Text] [Related]
29. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
[TBL] [Abstract][Full Text] [Related]
30. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
[TBL] [Abstract][Full Text] [Related]
31. Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy.
Lin Q; Li S; Jiang N; Jin H; Shao X; Zhu X; Wu J; Zhang M; Zhang Z; Shen J; Zhou W; Gu L; Lu R; Ni Z
Autophagy; 2021 Oct; 17(10):2975-2990. PubMed ID: 33345685
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
33. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
34. Hyperoside attenuates Cd-induced kidney injury via inhibiting NLRP3 inflammasome activation and ROS/MAPK/NF-κB signaling pathway in vivo and in vitro.
Li Z; Liao W; Yin X; Liu L; Zhao Z; Lu X; Xu F; Lin X; Chen Y; Song J; He Z; Wei Q; Wu W; Wu Y; Yang X
Food Chem Toxicol; 2023 Feb; 172():113601. PubMed ID: 36610472
[TBL] [Abstract][Full Text] [Related]
35. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
[TBL] [Abstract][Full Text] [Related]
36. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
37. [Cathepsin B Affects the Activation of Nucleotide-binding Domain and Leucine-rich-repeat-containing Family and Pyrin Domain-containing 3 Inflammasome via Transient Receptor Potential Mucolipin-1].
Duan JJ; Zhang QF; Huang ZH; Zeng HM; Bai H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):208-215. PubMed ID: 31060676
[TBL] [Abstract][Full Text] [Related]
38. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
39. Pirfenidone attenuates gentamicin-induced acute kidney injury by inhibiting inflammasome-dependent NLRP3 pathway in rats.
Sharawy MH; Serrya MS
Life Sci; 2020 Nov; 260():118454. PubMed ID: 32950575
[TBL] [Abstract][Full Text] [Related]
40. Renoprotective effects of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via suppressing NF-κB signaling and NLRP3 inflammasome activation by exosomes in rats.
Bai L; Li J; Li H; Song J; Zhou Y; Lu R; Liu B; Pang Y; Zhang P; Chen J; Liu X; Wu J; Liang C; Zhou J
Biochem Pharmacol; 2019 Nov; 169():113619. PubMed ID: 31465776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
